share_log

Should Weakness in Yunkang Group Limited's (HKG:2325) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Should Weakness in Yunkang Group Limited's (HKG:2325) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

鑑於財務狀況良好,雲康集團有限公司(HKG: 2325)股票的疲軟是否應該被視爲市場將修正股價的信號?
Simply Wall St ·  2023/12/21 18:00

Yunkang Group (HKG:2325) has had a rough three months with its share price down 6.6%. However, stock prices are usually driven by a company's financials over the long term, which in this case look pretty respectable. In this article, we decided to focus on Yunkang Group's ROE.

雲康集團(HKG: 2325)經歷了艱難的三個月,其股價下跌了6.6%。但是,從長遠來看,股票價格通常由公司的財務狀況驅動,在這種情況下,這看起來相當可觀。在本文中,我們決定重點關注雲康集團的投資回報率。

Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital. In simpler terms, it measures the profitability of a company in relation to shareholder's equity.

股本回報率或投資回報率是用於評估公司管理層利用公司資本效率的關鍵衡量標準。簡而言之,它衡量公司相對於股東權益的盈利能力。

View our latest analysis for Yunkang Group

查看我們對雲康集團的最新分析

How Do You Calculate Return On Equity?

你如何計算股本回報率?

The formula for ROE is:

投資回報率的公式是:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

股本回報率 = 淨利潤(來自持續經營)÷ 股東權益

So, based on the above formula, the ROE for Yunkang Group is:

因此,根據上述公式,雲康集團的投資回報率爲:

8.2% = CN¥187m ÷ CN¥2.3b (Based on the trailing twelve months to June 2023).

8.2% = 1.87億元人民幣 ÷ 23億元人民幣(基於截至2023年6月的過去十二個月)。

The 'return' refers to a company's earnings over the last year. That means that for every HK$1 worth of shareholders' equity, the company generated HK$0.08 in profit.

“回報” 是指公司去年的收益。這意味着,每獲得價值1港元的股東權益,該公司就會產生0.08港元的利潤。

Why Is ROE Important For Earnings Growth?

爲什麼投資回報率對收益增長很重要?

So far, we've learned that ROE is a measure of a company's profitability. Depending on how much of these profits the company reinvests or "retains", and how effectively it does so, we are then able to assess a company's earnings growth potential. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don't share these attributes.

到目前爲止,我們已經了解到,投資回報率是衡量公司盈利能力的指標。然後,根據公司對這些利潤進行再投資或 “保留” 的金額及其有效性,我們就能評估公司的盈利增長潛力。一般而言,在其他條件相同的情況下,股本回報率和利潤保留率高的公司比不具備這些屬性的公司的增長率更高。

Yunkang Group's Earnings Growth And 8.2% ROE

雲康集團的收益增長和8.2%的投資回報率

On the face of it, Yunkang Group's ROE is not much to talk about. However, given that the company's ROE is similar to the average industry ROE of 9.6%, we may spare it some thought. Particularly, the exceptional 31% net income growth seen by Yunkang Group over the past five years is pretty remarkable. Considering the moderately low ROE, it is quite possible that there might be some other aspects that are positively influencing the company's earnings growth. For instance, the company has a low payout ratio or is being managed efficiently.

從表面上看,雲康集團的投資回報率沒什麼好談的。但是,鑑於該公司的投資回報率與9.6%的行業平均投資回報率相似,我們可以不加思索。特別是,雲康集團在過去五年中實現了31%的驚人淨收入增長,這非常引人注目。考慮到投資回報率適中,很可能還有其他一些方面對公司的收益增長產生積極影響。例如,該公司的派息率較低或管理效率很高。

Next, on comparing with the industry net income growth, we found that Yunkang Group's growth is quite high when compared to the industry average growth of 11% in the same period, which is great to see.

接下來,與行業淨收入增長相比,我們發現,與同期行業平均增長11%相比,雲康集團的增長相當高,這真是太好了。

past-earnings-growth
SEHK:2325 Past Earnings Growth December 21st 2023
SEHK: 2325 過去的收益增長 2023 年 12 月 21 日

The basis for attaching value to a company is, to a great extent, tied to its earnings growth. What investors need to determine next is if the expected earnings growth, or the lack of it, is already built into the share price. This then helps them determine if the stock is placed for a bright or bleak future. Has the market priced in the future outlook for 2325? You can find out in our latest intrinsic value infographic research report.

爲公司附加價值的基礎在很大程度上與其收益增長息息相關。投資者接下來需要確定的是,預期的收益增長或缺乏收益是否已經包含在股價中。然後,這可以幫助他們確定股票是面向光明還是暗淡的未來。市場對2325的未來展望進行了定價嗎?您可以在我們最新的內在價值信息圖研究報告中找到答案。

Is Yunkang Group Using Its Retained Earnings Effectively?

雲康集團是否在有效使用其留存收益?

While the company did pay out a portion of its dividend in the past, it currently doesn't pay a dividend. This is likely what's driving the high earnings growth number discussed above.

儘管該公司過去確實支付了部分股息,但目前不支付股息。這可能是推動上述高收益增長數字的原因。

Conclusion

結論

On the whole, we do feel that Yunkang Group has some positive attributes. Despite its low rate of return, the fact that the company reinvests a very high portion of its profits into its business, no doubt contributed to its high earnings growth. That being so, a study of the latest analyst forecasts show that the company is expected to see a slowdown in its future earnings growth. To know more about the company's future earnings growth forecasts take a look at this free report on analyst forecasts for the company to find out more.

總的來說,我們確實認爲雲康集團有一些積極的屬性。儘管回報率很低,但該公司將其利潤的很大一部分再投資於其業務這一事實無疑促進了其高收益增長。既然如此,對分析師最新預測的研究表明,預計該公司未來的收益增長將放緩。要了解有關公司未來收益增長預測的更多信息,請查看這份關於分析師預測的免費報告,以了解更多信息。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St 的這篇文章本質上是籠統的。我們僅使用公正的方法提供基於歷史數據和分析師預測的評論,我們的文章並非旨在提供財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不會考慮最新的價格敏感型公司公告或定性材料。華爾街只是沒有持有上述任何股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論